Peter Atadja - 15 Dec 2022 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Role
Director
Signature
/s/ Mark Guerin, Attorney-in-Fact
Issuer symbol
TRAW
Transactions as of
15 Dec 2022
Net transactions value
$0
Form type
4
Filing time
19 Dec 2022, 17:56:35 UTC
Next filing
14 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONTX Stock Option (right to purchase) Award $0 +100,000 $0.000000 100,000 15 Dec 2022 Common Stock 100,000 $0.7100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest in 3 installments on the anniversary of the grant date: 33% on the first anniversary, 33% on the second anniversary and 34% on the third anniversary.